Cargando…
Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy
INTRODUCTION: The minimum criterion for the diagnosis of hypertrophic cardiomyopathy (HCM) is thickening of the left ventricular wall, typically in an asymmetrical or focal fashion, and it requires no functional deficit. Using this criterion, we identified a family with four affected individuals and...
Autores principales: | Mouton, Jomien M, Kinnear, Craig J, Moolman-Smook, Johanna C, Herbst, Philip G, Pellizzon, Adriano S, Goosen, Althea, Brink, Paul A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815569/ https://www.ncbi.nlm.nih.gov/pubmed/25940119 http://dx.doi.org/10.5830/CVJA-2015-019 |
Ejemplares similares
-
Long-term follow-up of R403W(MYH7) and R92W(TNNT2) HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression
por: Revera, Miriam, et al.
Publicado: (2007) -
Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch
por: Brink, PA, et al.
Publicado: (2009) -
Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
por: van der Merwe, Lize, et al.
Publicado: (2008) -
Filamin C: a novel component of the KCNE2 interactome during hypoxia
por: Neethling, Annika, et al.
Publicado: (2016) -
Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C
por: Uys, Gerrida M, et al.
Publicado: (2011)